Trever Bivona, MD, PhD
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA
Dr. Bivona is a cell and molecular biologist and a board-certified medical oncologist. He received his MD and PhD degrees from NYU School of Medicine, followed by internal medicine training at the Brigham and Women’s Hospital/Harvard Medical School in Boston, and medical oncology and post-doctoral research training at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Bivona then joined the faculty at the University of California, San Francisco where he is currently an Associate Professor and directs a basic and translational research program investigating oncogene signaling pathways and the molecular basis of response and resistance to cancer therapeutics. He received a NIH Director’s New Innovator Award and is an elected member of the American Society for Clinical Investigation. Dr. Bivona is currently Principal Investigator of the NIH/NCI Bay Area Drug Resistance and Sensitivity Center.